We’re quickly approaching a time when artificial intelligence will be fully incorporated into a myriad of marijuana-related functions. Read More

California lawmakers have passed a psychedelics decriminalization bill and Governor Gavin Newsom will probably sign it. The money race is on. Read More

A new report reveals a dichotomy in choices between those who are veteran purchasers of cannabis, and the newbies to the market. Read More

Psychedelics once demonized by polite society are now being deployed by the government and medical establishment to combat tobacco addiction. Read More

Health and Human Services announced this week that it’s asking the Drug Enforcement Administration to move cannabis from Schedule I to Schedule III. Read More

Consumption rates among Americans of marijuana and hallucinogenic substances are at historic levels. Investors are taking notice. Read More

New research shows that psilocybin can be more effective and less expensive than conventional drug therapies for severe depression. Read More

The German government approved legislation this week that would allow adults to buy and possess recreational cannabis. The stakes are huge. Read More

It may be the dog days of August, but legal, regulatory, and political trends that affect the worldwide cannabis sector continue apace. Read More

Cannabidiol (CBD) is evolving into a mainstream consumer product. CBD won’t make you high, but it can make you rich. Read More